000424

1995, September, 95-97.

170. Olsson, S. The Role of the WHO Programme on international

drug monitoring in coordinating worldwide drug safety efforts / S.Olsson //

Drug Safety, 1998/ - 19: 1-10.

171. Pharmacokinetic evaluation of linezolid in patients with major

thermal injuries / R. Le Floch [et al.] // PatholBiol. - 2010. - Apr; 58(2): p. 27

31.

172. Pirmohamed, M. Adverse drug reactions / M. Pirmohamed, A.M.

Breckenridge, N.R. Kitteringham, B.K Park // BMJ, 1998; 316:1295-1298 (25

April).

173. Pirmohamed, M. Adverse drug reactions / M. Pirmohamed, A.M.

Breckenridge, N.R. Kitteringham, B.K. Park // BMJ, 1998; 316:1295-1298

(25 April).

174. Rodriguez-Monguio R. Assessing the economic impact of adverse

drug effects / R. Rodriguez-Monguio, M. Otero, J. Rovira //

Pharmacoeconomics. - 2003; 21(9): 623-50.

175. Rupp, M.T. Value of Community Pharmacists’ Interventions to

Correct Prescribing Errors / M.T Rupp. - Annals of Pharmacotherapy, 1992;

26: 1580-1584.

176. Sarpal, N. Drag administration - Infusion Devices’, in Dougherty

L. and Lister S (editors). - 2008. - The Royal Marsden Hospital Manual of

clinical nursing procedures (7th edition), Oxford: Blackwell Publishing. (III).

177. Schoenemann, J. Unerwunschte Arzneimittelwirkungen in der

klinik / J. Schoenemann, K.H. Munter, S. Enayati Kashani // Dtsch. Med.

Wochenschr., 1998, 123 (15), 448-452.

178. Schousboe, L.P. O Correct documentation of drug prescriptions /

L.P. Schousboe, O. Tandrup // Ugeskr. Laeger, 1999, 2, 161(31), 4389-4392.

179. Seeger, J.D. Characteristics associated with ability to prevent

adverse drug reactions in hospitalized patients / J.D. Seeger, S.X. Kong, G.T.

196